Cinven and Bain Capital-backed Arxada completed the merger with Troy.

Cinven and Bain Capital-backed Arxada, a global specialty chemicals business, completed the merger with Troy, a global provider of microbial control solutions and performance additives. Financial terms were not disclosed. "The combination of Arxada and Troy will reinforce our position as a leading global provider of microbial control solutions. Our decision to merge with Troy just four months after our launch as an independent company highlights our ambition and commitment to creating the broadest and most innovative solutions for our customers in this sector. The combination also fits with our strategy of expanding our geographic footprint and the scale and depth of our capabilities by bolstering our manufacturing capacity in MCS beyond North America into Europe and Asia," Marc Doyle, Arxada CEO.